GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLNE) » Definitions » Other Long Term Assets

Actelion (XSWX:ATLNE) Other Long Term Assets : CHF38 Mil (As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Actelion Other Long Term Assets?

Actelion's other long-term assets for the quarter that ended in Mar. 2017 was CHF38 Mil.

Actelion's quarterly other long-term assets increased from Sep. 2016 (CHF44 Mil) to Dec. 2016 (CHF46 Mil) but then stayed the same from Dec. 2016 (CHF46 Mil) to Mar. 2017 (CHF38 Mil).

Actelion's annual other long-term assets declined from Dec. 2014 (CHF78 Mil) to Dec. 2015 (CHF56 Mil) and declined from Dec. 2015 (CHF56 Mil) to Dec. 2016 (CHF46 Mil).

Actelion Other Long Term Assets Historical Data

The historical data trend for Actelion's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Other Long Term Assets Chart

Actelion Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 416.76 37.53 78.33 55.57 45.68

Actelion Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.31 52.11 44.04 45.68 38.03

Actelion Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Actelion (XSWX:ATLNE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLNE) » Definitions » Other Long Term Assets
Comparable Companies
ALXN XKRX:207940 SGEN REGN INCY XKRX:068270 HKSE:01177 XBRU:UCB OCSE:GMAB HKSE:02269 BMRN HKSE:06160 XAMS:GLPG ALNY ARRY NBIX SZSE:300122 IONS JAZZ TECH
Traded in Other Exchanges
N/A
Address
Website
http://www.actelion.com
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (XSWX:ATLNE) Headlines

No Headlines